Green dye tweak could make cancer surgery cheaper and more accurate
NCT ID NCT07380698
First seen Feb 02, 2026 · Last updated Jun 22, 2026 · Updated 18 times
Summary
This study looks at whether changing the dose and how a green dye (indocyanine green) is stored can help doctors find cancer in lymph nodes more accurately during surgery for cervical, endometrial, and vulvar cancers. The goal is to make the procedure safer, more effective, and less expensive. Thirty patients will take part, and researchers will measure how often the dye successfully spots the sentinel lymph node and how much the procedure costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cukurova University
RECRUITINGAdana, 01000, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
indocyanine green (ICG) dye
What this could lead to
If successful, this could lead to a safer, cheaper, and more effective way to find cancer spread in the lymph nodes during gynecologic cancer surgery.
What could go wrong
This is a very small, early-stage study (30 people) focused on optimizing a dye, not testing a new treatment. The results may not apply to all patients or hospitals.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.